Dr. Smith is an assistant professor at Washington State University in the Elson S. Floyd College of Medicine Department of Community and Behavioral Health and the Human Development Prevention Science program. For over a decade, she has been actively engaged with the Program for Excellence in Addictions Research, and she recently established the Laboratory for Innovations in Therapeutics, wherein her research focuses on substance use disorder (SUD) treatment optimization and precision medicine interventions.

Dr. Smith enters the C-DIAS Fellowship with an active NIDA K01 grant, Pharmacogenomic Testing to Optimize Opioid Use Disorder Treatment: Acceptability and Feasibility Trial. This K01 will allow Dr. Smith to establish a program of research in the ethical implementation of pharmacogenomic testing in SUD treatment. Through the fellowship, Dr. Smith plans to gain expertise in theory, design, sustainability, and rigorous application of dissemination and implementation science, so she can effectively translate precision medicine into clinical care for SUD, using strategies that are both effective and scalable. She will develop a study focused on the implementation of pharmacogenomic testing into routine MOUD clinical care using a hybrid type 1 effectiveness-implementation design, the Consolidated Framework for Implementation Science, and consistent engagement with key stakeholders.